"Feb. 18, 2011 -- New guidelines for the treatment of the skin condition psoriasis stress the importance of tailoring therapies to individual patients.
The guidelines were issued by the American Academy of Dermatology.
Amevive Patient Information including How Should I Take
In this Article
- What is alefacept (Amevive)?
- What are the possible side effects of alefacept (Amevive)?
- What is the most important information I should know about alefacept (Amevive)?
- What should I discuss with my healthcare provider before using alefacept (Amevive)?
- How should I use alefacept (Amevive)?
- What happens if I miss a dose (Amevive)?
- What happens if I overdose (Amevive)?
- What should I avoid while using alefacept (Amevive)?
- What other drugs will affect alefacept (Amevive)?
- Where can I get more information?
What should I discuss with my healthcare provider before using alefacept (Amevive)?
Patients with HIV should not take alefacept. Talk to your doctor before taking alefacept if you are HIV positive.
Do not use alefacept without first talking to your doctor if you
- have had a previous allergic reaction to alefacept;
- have heart or blood vessel problems;
- have cancer or a history of cancer;
- have an infection or a history of chronic infection; or
- are taking another immunosuppressive medication or are receiving phototherapy.
You may not be able to use alefacept, or you may require a dosage adjustment or special monitoring during treatment.
Alefacept is in the FDA pregnancy category B. This means that it is not expected to be harmful to an unborn baby. Do not use alefacept without first talking to your doctor if you are pregnant or could become pregnant during treatment.
It is not known whether alefacept passes into breast milk. Do not use alefacept without first talking to your doctor if you are breast-feeding a baby.
How should I use alefacept (Amevive)?
Use alefacept exactly as directed by your doctor. If you do not understand these instructions, ask your doctor, nurse, or pharmacist to explain them to you.
Alefacept is administered by a healthcare provider as an intravenous (into the vein) or intramuscular (into the muscle) injection.
Alefacept is usually administered once a week for a twelve week period. Your doctor will give you detailed information on the best treatment regimen for you.
It is important to use alefacept regularly to get the most benefit.
Alefacept reduces levels of certain white blood cells in the body. If the level of these white blood cells falls too low, treatment with alefacept may need to be withheld temporarily or discontinued. Your doctor will monitor your white blood cell levels during treatment.
Your doctor will want you to have blood tests or other medical evaluations during treatment with alefacept to monitor progress and side effects
Alefacept will be stored by your healthcare provider as directed by the manufacturer.
Additional Amevive Information
- Amevive Drug Interactions Center: alefacept im
- Amevive Side Effects Center
- Amevive Overview including Precautions
- Amevive FDA Approved Prescribing Information including Dosage
Amevive - User Reviews
Amevive User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.